Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Thrombocytopenia 1Neutropenia 1Anemia 1

Interventions

Filgrastim 6pegylated granulocyte colony-stimulating factor 4pegfilgrastim 4Vancomycin 3Etoposide 3Cytarabine 3Cefepime 3Amikacin 3Teicoplanin 2Methotrexate 2Meropenem 2Granulocyte Colony-Stimulating Factor 2Daunorubicin 2Cyclosporine 2Ciprofloxacin 2Ceftazidime 2ziprasidone 1niraparib 1lintuzumab 1leridistim 1fludarabine phosphate 1angiotensin I (1-7) 1Zolpidem 1Warfarin 1Vitamin B 12 1Vincristine 1Vecuronium Bromide 1Transplantation 1Tranexamic Acid 1Tobramycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neutropenia × CP protocol × Classical hematology × Clear all
NCT05963334 2023-07-27

Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer

Cairo University

Phase 1/2 Completed
49 enrolled
Classical hematology

Anemia, Neutropenia, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡